Medical News

RSS

VG Life Sciences receives U.S. patent for combination cancer therapy

VG Life Sciences, Inc., a biotechnology company developing therapies for cancer, autoimmune and infectious diseases, announced that the U.S. Patent and Trademark Office will issue Patent No. 9073985 covering VGLS' combination therapy for treating drug-resistant cancer by combining an autophagy inhibitor with a chemotherapy drug.

22 Jun 2015

Tackling fuel poverty can help reduce debilitating sickle cell disease, save significant money for NHS

Tackling fuel poverty in the homes of people with sickle cell disease could reduce debilitating attacks and save significant money for the NHS, according to a study by Sheffield Hallam University funded by the Chesshire Lehmann Fund.

22 Jun 2015

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into these areas have been facilitated by the commencement of a collaboration with UK-based stem cell therapeutics company, ReNeuron.

22 Jun 2015

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

Ortho Clinical Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the VITROS Chemistry Products HbA1c Reagent Kit to be used on the VITROS 5600 Integrated System, VITROS 4600 Chemistry System, and the VITROS 5,1 FS Chemistry System. The test can be used for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood.

From Ortho-Clinical Diagnostics, Inc. 22 Jun 2015

DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment

DC Devices, Inc., a medical device company pioneering first-in-class structural heart devices for heart failure, today announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an open label, multi-center, single-arm study of the InterAtrial Shunt Device (IASD) – the world's first transcatheter device for the treatment of diastolic heart failure (DHF), which is also known as heart failure with preserved ejection fraction (HFpEF).

22 Jun 2015

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 study in children with SMA

Isis Pharmaceuticals, Inc. today provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMN Rx and are continuing to receive treatment in an open-label extension (OLE) study.

22 Jun 2015

Finding may pave way for much-needed treatments for people with epilepsy

An amino acid whose role in the body has been all but a mystery appears to act as a potent seizure inhibitor in mice, according to a study by researchers at Johns Hopkins.

22 Jun 2015

DePuy Synthes Companies, AO Foundation sign cooperation agreement to improve patient outcomes

The DePuy Synthes Companies of Johnson & Johnson today announced that the company has signed a five-year cooperation agreement with the AO Foundation to continue the work they began together in 1960 to deliver world-class professional education and develop new innovations that improve patient outcomes and increase efficiency of care.

22 Jun 2015

Vaxil's ImMucin receives FDA orphan drug designation for treatment of multiple myeloma

Vaxil Bio, a company specializing in the development of immunotherapy-based drugs, reports today that its lead product, ImMucin, has been granted an "orphan drug" designation by the US Food and Drug Administration, for the treatment of multiple myeloma (MM).

22 Jun 2015

Near-infrared imaging techniques for visualization of cartilage tissue

The mainstream techniques for visualization of cartilage tissue in the body are magnetic resonance imaging and computer tomography, but both techniques do not provide optimum quality images.

22 Jun 2015

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Advanced Cell Diagnostics, Inc., a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, announced today that it has raised $22 million in Series C equity financing, led by growth equity investor Summit Partners with participation from Kenson Ventures and existing investors, Morningside Ventures and New Leaf Venture Partners.

From Advanced Cell Diagnostics 22 Jun 2015

Experimental vaccine candidate can stimulate immune system activity to prevent HIV infection

New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine candidate designed at TSRI can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine.

22 Jun 2015

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Oraya Therapeutics Inc.and Bridge Design announced today that the Oraya IRay Radiotherapy System has won the Silver award in the radiological and electromechanical devices category of the 18 Annual Medical Design Excellence Awards (MDEA).The winners were announced at a ceremony in New York City at the Jacob Javits Center in conjunction with the MD&M East event.

22 Jun 2015

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

ExamMed, the only universal healthcare technology platform, offering providers an ideal patient-centered, complete model of care, both virtual and in-office, recently selected Trevelino/Keller as its principal integrated PR and marketing agency.

22 Jun 2015

New research sheds light on molecular architecture of receptors linked to many brain diseases

Scientists at The Scripps Research Institute have teamed up with several other institutions and pharmaceutical companies, including the University of Southern California (USC), San Diego's Receptos Inc. and Japanese company Ono Pharmaceutical Co., Ltd., to publish the first 3D structures of a receptor implicated in many diseases of the brain and in normal physiology throughout the body.

22 Jun 2015

Scientists identify safe repellent that protects fruits from D. suzukii

Insects destroy a very large fraction of the global agricultural output - nearly 40 percent. The spotted wing Drosophila (Drosophila suzukii), for example, feeds on ripening fruits. A nuisance especially in Northern California and Europe, it lays its eggs inside ripe berries, and, when its larvae emerge there, the fruit is destroyed.

22 Jun 2015

Readmission to same hospital for post-surgical complications improves survival

Patients rehospitalized with complications after major surgery are 26% more likely to survive if they return to the hospital where they had their operation compared to those readmitted to a different hospital, according to a national study involving over 9 million Medicare patients in the USA, published in The Lancet.

22 Jun 2015

ImmunoCellular, Pure MHC partner to develop new assay for ICT-107 phase 3 registrational clinical program

ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.

22 Jun 2015

Researchers use different approaches to test ways to manipulate nanoparticles in medicine

Nanoparticles are the smallest particles capable of reaching virtually all parts of the body. Researchers use various approaches to test ways in which nanoparticles could be used in medicine - for instance, to deliver substances to a specific site in the body such as a tumor.

22 Jun 2015

TSRI scientists devise powerful set of chemical methods to explore protein biology

Scientists at The Scripps Research Institute (TSRI) have devised a powerful set of chemical methods for exploring the biology of proteins.

22 Jun 2015

Medical News

VG Life Sciences receives U.S. patent for combination cancer therapy

Tackling fuel poverty can help reduce debilitating sickle cell disease, save significant money for NHS

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Ortho Clinical Diagnostics announces FDA approval of VITROS Chemistry Products HbA1c Reagent Kit for diagnosis of diabetes

DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 study in children with SMA

Finding may pave way for much-needed treatments for people with epilepsy

DePuy Synthes Companies, AO Foundation sign cooperation agreement to improve patient outcomes

Vaxil's ImMucin receives FDA orphan drug designation for treatment of multiple myeloma

Near-infrared imaging techniques for visualization of cartilage tissue

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Experimental vaccine candidate can stimulate immune system activity to prevent HIV infection

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

New research sheds light on molecular architecture of receptors linked to many brain diseases

Scientists identify safe repellent that protects fruits from D. suzukii

Readmission to same hospital for post-surgical complications improves survival

ImmunoCellular, Pure MHC partner to develop new assay for ICT-107 phase 3 registrational clinical program

Researchers use different approaches to test ways to manipulate nanoparticles in medicine

TSRI scientists devise powerful set of chemical methods to explore protein biology

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News